Bath & Body Works Inc is a retail company specializing in personal care products, home fragrances, and skincare items
Known for its signature range of scented candles, lotions, and shower gels, the brand focuses on creating high-quality, innovative products that enhance the daily self-care rituals of its customers. With a strong emphasis on creating inviting shopping experiences, Bath & Body Works operates extensive brick-and-mortar locations as well as a robust online presence, appealing to a broad customer base through seasonal promotions and unique fragrance offerings. The company is dedicated to sustainability and ethical sourcing, continually striving to connect with consumers who value quality and a sense of well-being.
Bath & Body Works stock rose slightly after reporting Q4 results. JPMorgan and Telsey maintain buy ratings with price targets of $47 and $43, respectively
Shares of personal care and home fragrance retailer Bath & Body Works (NYSEBBWI)
fell 12.8% in the afternoon session after the company reported weak fourth-quarter results: Sales declined 4.3% year-on-year, partly due to a calendar shift. Looking ahead, the company expects full-year revenue to grow modestly by 1% to 3%, with EPS projected to decline compared to the prior year.
Meanwhile, Bath & Body Works exceeded analysts' EBITDA expectations this quarter, and its gross margin slightly outperformed Wall Street estimates. However, despite these positive aspects, overall performance remained weak.
Personal care and home fragrance retailer Bath & Body Works (NYSEBBWI) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 4.3% year on year to $2.79 billion. On the other hand, next quarter’s revenue guidance of $1.41 billion was less impressive, coming in 1% below analysts’ estimates. Its GAAP profit of $2.09 per share was 3.2% above analysts’ consensus estimates.
Bath & Body Works shares fall after reporting a 4.3% year-over-year decline in Q4 sales, totaling $2.788 billion. Despite the decline, EPS of $2.09 beat estimates. The company's operating income decreased by 2.6%.
Personal care and home fragrance retailer Bath & Body Works (NYSEBBWI)
will be announcing earnings results tomorrow before market open. Here’s what you need to know.
Shares of personal care and home fragrance retailer Bath & Body Works (NYSEBBWI)
jumped 9.1% in the morning session after JP Morgan upgraded the stock's rating from Neutral to Buy. The firm added "Our recent fieldwork and management access points to a fundamental inflection on both the top and bottom-line into FY25 upgrading BBWI to Overweight raising our Dec '25 price target to $47."
As the stock market excess concentrates in the S&P 500 and large-cap stocks, investors have reasons to believe that small caps could start to outperform.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at beauty and cosmetics retailer stocks, starting with Bath and Body Works (NYSEBBWI).
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Warby Parker (NYSEWRBY) and its peers.
Retailers are adapting their business models as technology changes how people shop. Still, demand can be volatile as the industry is exposed to the ups and downs of consumer spending.
This has stirred some uncertainty lately as retail stocks have lagged the market over the past six months, posting a return of 11.1% compared to 16.8% for the S&P 500.
Exploring BATH & BODY WORKS INC's Technical Signals and Breakout Potential: Based on good technical signals, BATH & BODY WORKS INC is potentially setting up for a breakout.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Best Buy (NYSEBBY) and its peers.
